Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 48

Sort by

Sort Order Select

Journal Articles

M6PR-Specific Targeting of Lysosomal Heparanase Regulates Platelet Hemostatic Function in Mice

Nathan Eaton, BS, Caleb Drew, BS, Theresa A. Dlugi, PhD, Karin M. Hoffmeister, MD, Hervé Falet, PhD

Blood (2019) 134 (Supplement_1): 1059.

https://doi.org/10.1182/blood-2019-129075

Published: 2019

Journal Articles

Defects in Signal Recognition Particle (SRP) Components Reveal an Essential and Non-Redundant Role for Granule Biogenesis and Differentiation of Neutrophil Granulocytes

Blood (2019) 134 (Supplement_1): 216.

https://doi.org/10.1182/blood-2019-130083

Published: 2019

Journal Articles

Altered Carbonylation Pattern in Myelodisplastic Syndromes

María Linares, PhD, Alba Rodríguez-García, Keina Quiroz, Maria Teresa Cedena, Alicia Arenas, PhD, Maria Luz Morales, Laura Sánchez-Vega, Rosa Ayala, Jose Manuel Bautista, Joaquín Martínez

Blood (2017) 130 (Supplement 1): 5302.

https://doi.org/10.1182/blood.V130.Suppl_1.5302.5302

Published: 2017

Journal Articles

5q+ MDS Patients with Low RPS14 Expression Are Candidates to Immune-Modulating Drugs

María Linares, PhD, Inmaculada Rapado, Yanira Ruiz-Heredia, Maria Teresa Cedena, Keina Quiroz, Santiago Barrio, PhD, Rosa Ayala, Joaquín Martínez

Blood (2017) 130 (Supplement 1): 5303.

https://doi.org/10.1182/blood.V130.Suppl_1.5303.5303

Published: 2017

Journal Articles

Comparison of ABL1 and Gusb Reference Genes in the qRT-PCR Analysis of Halving Time and Early Molecular Response to TKI Therapy in Patients with Chronic Myeloid Leukemia

Joanna Wącław, MD, Magdalena Zawada, PhD, Sylwia Czekalska, PhD, Bogdan Ochrem, MD, Tomasz Sacha

Blood (2016) 128 (22): 5424.

https://doi.org/10.1182/blood.V128.22.5424.5424

Published: 2016

Journal Articles

Functional rs4693608 SNP is Located into Strong Hpse Gene Intron Enhancer and Thereby Influences to the Ability of Nuclear Proteins Binding and Activity of This Enhancer in Broad Number of Hematological Cell Lines and ALL/AML Primary Samples

Olga Ostrovsky, PhD, Ania Hava Grushchenko Polaq, Katia Beider, PhD, Rita Mayorov, Avichai Shimoni, MD, Israel Vlodavsky, PhD, Arnon Nagler

Blood (2016) 128 (22): 3934.

https://doi.org/10.1182/blood.V128.22.3934.3934

Published: 2016

Journal Articles

SGN-CD48A: a Novel Humanized Anti-CD48 Antibody-Drug Conjugate for the Treatment of Multiple Myeloma

Tim S. Lewis, PhD, Devra Olson, B.S., Kristine Gordon, B.S., Sharsti Sandall, PhD, Marsha Quick, B.S., Margo Finn, B.S., Lori Westendorf, B.S., Germein Linares, B.S., Chris Leiske, B.S., Albina Nesterova, B.S., Lanshan Huang, B.S., Maitrayee Goswami, B.S., Sa Wang, MD, Che-Leung Law, PhD

Blood (2016) 128 (22): 4470.

https://doi.org/10.1182/blood.V128.22.4470.4470

Published: 2016

Journal Articles

High BCR-ABL/GUS IS Levels at Diagnosis Are Associated with Unfavorable Responses to Standard Dose Imatinib

Blood (2015) 126 (23): 4049.

https://doi.org/10.1182/blood.V126.23.4049.4049

Published: 2015

Journal Articles

Roneparstat (SST0001), an Innovative Heparanase (HPSE) Inhibitor for Multiple Myeloma (MM) Therapy: First in Man Study

Monica Galli, MD, Hila Magen, MD, Hermann Einsele, Manik Chatterjee, MD, Mariella Grasso, MD, Giorgina Specchia, Paola Barbieri, MD, David Paoletti, MS, Silvia Pace, MS, Ralph D Sanderson, PhD, Alessandro Rambaldi, MD, Arnon Nagler, MD MSc

Blood (2015) 126 (23): 3246.

https://doi.org/10.1182/blood.V126.23.3246.3246

Published: 2015

Journal Articles

High Expression of Myocyte Enhancer Factor 2C ( MEF2C ) Is Associated with Adverse Risk Features and Poor Outcome in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group

George S. Laszlo, PhD, Todd A. Alonzo, PhD, Chelsea J. Gudgeon, BS, Kimberly H. Harrington, BS, Alex Kentsis, MD PhD, Robert B. Gerbing, MA, Yi-Cheng Wang, MS, Rhonda E. Ries, MA, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Alan S. Gamis, MD MPH, Soheil Meshinchi, MD PhD, Roland B. Walter, MD PhD MS

Blood (2015) 126 (23): 2570.

https://doi.org/10.1182/blood.V126.23.2570.2570

Published: 2015

Journal Articles

Multimerin-1 (MMRN1) As Novel Adverse Prognostic Marker in Acute Myeloid Leukemia: A Report from the Children’s Oncology Group

George S. Laszlo, PhD, Todd A. Alonzo, PhD, Chelsea J. Gudgeon, BS, Kimberly H. Harrington, BS, Robert B. Gerbing, MA, Yi-Cheng Wang, MS, Rhonda E. Ries, MA, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Alan S. Gamis, MD MPH, Soheil Meshinchi, MD PhD, Roland B. Walter, MD PhD MS

Blood (2014) 124 (21): 2330.

https://doi.org/10.1182/blood.V124.21.2330.2330

Published: 2014

Journal Articles

MLL-Rearranged Infant ALL, but Not Standard-Risk ALL, Induces Inflammasome Signaling and Immune Activation

Jessica C Shand, MD, Jinno Magno, Michael Weinstein Winter, MD, Liana M Toia

Blood (2014) 124 (21): 3660.

https://doi.org/10.1182/blood.V124.21.3660.3660

Published: 2014

Journal Articles

Comparing the Prognostic Significance of Early Predictors of Survival in Chronic Myeloid Leukemia (CML) Treated with Imatinib - an Analysis of the Randomized CML-Study IV

Blood (2014) 124 (21): 156.

https://doi.org/10.1182/blood.V124.21.156.156

Published: 2014

Journal Articles

Aldosterone Stimulates Neutrophils Leading To Increased β-Glucuronidase, Protein Disulfide Isomerase and Myeloperoxidase Secretion

Arelys Ramos-Rivera, MD, Alicia Rivera, MS, PhD, Enrique D. Machado-Fiallo, BS, Josue A. Benabe-Carlo, BS, Gregory N. Prado, PhD, Jose R Romero, PhD

Blood (2013) 122 (21): 2271.

https://doi.org/10.1182/blood.V122.21.2271.2271

Published: 2013

Journal Articles

MDR1 Gene Expression Predicts Response and Progression-Free Survival Of Ph+ CML Patients On Second-Line Nilotinib Therapy After Imatinib Failure - 4-Year Follow-Up

Mridul Agrawal, Benjamin Hanfstein, MD, Philipp Erben, MD, Dominik Wolf, MD, Thomas Ernst, Susanne Saussele, MD, Alice Fabarius, PhD, Das Purkayasatha, Richard C. Woodman, MD, Rüdiger Hehlmann, MD, Wolf-Karsten Hofmann, MD, Andreas Hochhaus, MD, Martin C. Müller, MD

Blood (2013) 122 (21): 1494.

https://doi.org/10.1182/blood.V122.21.1494.1494

Published: 2013

Journal Articles

High BCR-ABL/GUS IS Levels At Diagnosis Are Associated With Unfavorable Responses To Imatinib

Blood (2013) 122 (21): 1495.

https://doi.org/10.1182/blood.V122.21.1495.1495

Published: 2013

Journal Articles

Optimizing Early Prediction Of Outcome In CML Using The Exact Decline Of BCR-ABL Transcript Levels Within 3 Months Of Imatinib Treatment As a Prognostic Marker

Blood (2013) 122 (21): 253.

https://doi.org/10.1182/blood.V122.21.253.253

Published: 2013

Journal Articles

Aldosterone Stimulates a Degranulation Response in Human Neutrophils: Role of Protein Disulfide Isomerase

Daphne Diaz, BS, Gregory N. Prado, PhD, Patricia Neuman, BS, Adriana Nieva, MS, Manuel Torres-Grajales, Alicia Rivera, MS, PhD, Jose R Romero, PhD

Blood (2012) 120 (21): 1034.

https://doi.org/10.1182/blood.V120.21.1034.1034

Published: 2012

Journal Articles

Absolute BCR-ABL Transcript Levels At 3 Months but Not At Diagnosis Predict Survival of Chronic Myeloid Leukemia (CML) Patients On Imatinib Therapy

Blood (2012) 120 (21): 3761.

https://doi.org/10.1182/blood.V120.21.3761.3761

Published: 2012

Journal Articles

High BCR-ABL Levels At Diagnosis Are Associated with Unfavorable Responses to Imatinib Mesylate.

Blood (2012) 120 (21): 2790.

https://doi.org/10.1182/blood.V120.21.2790.2790

Published: 2012

NARROW

M6PR-Specific Targeting of Lysosomal Heparanase Regulates Platelet Hemostatic Function in Mice

Defects in Signal Recognition Particle (SRP) Components Reveal an Essential and Non-Redundant Role for Granule Biogenesis and Differentiation of Neutrophil Granulocytes

Altered Carbonylation Pattern in Myelodisplastic Syndromes

5q+ MDS Patients with Low RPS14 Expression Are Candidates to Immune-Modulating Drugs

Comparison of ABL1 and Gusb Reference Genes in the qRT-PCR Analysis of Halving Time and Early Molecular Response to TKI Therapy in Patients with Chronic Myeloid Leukemia

Functional rs4693608 SNP is Located into Strong Hpse Gene Intron Enhancer and Thereby Influences to the Ability of Nuclear Proteins Binding and Activity of This Enhancer in Broad Number of Hematological Cell Lines and ALL/AML Primary Samples

SGN-CD48A: a Novel Humanized Anti-CD48 Antibody-Drug Conjugate for the Treatment of Multiple Myeloma

High BCR-ABL/GUS IS Levels at Diagnosis Are Associated with Unfavorable Responses to Standard Dose Imatinib

Roneparstat (SST0001), an Innovative Heparanase (HPSE) Inhibitor for Multiple Myeloma (MM) Therapy: First in Man Study

High Expression of Myocyte Enhancer Factor 2C ( MEF2C ) Is Associated with Adverse Risk Features and Poor Outcome in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group

Multimerin-1 (MMRN1) As Novel Adverse Prognostic Marker in Acute Myeloid Leukemia: A Report from the Children’s Oncology Group

MLL-Rearranged Infant ALL, but Not Standard-Risk ALL, Induces Inflammasome Signaling and Immune Activation

Comparing the Prognostic Significance of Early Predictors of Survival in Chronic Myeloid Leukemia (CML) Treated with Imatinib - an Analysis of the Randomized CML-Study IV

Aldosterone Stimulates Neutrophils Leading To Increased β-Glucuronidase, Protein Disulfide Isomerase and Myeloperoxidase Secretion

MDR1 Gene Expression Predicts Response and Progression-Free Survival Of Ph+ CML Patients On Second-Line Nilotinib Therapy After Imatinib Failure - 4-Year Follow-Up

High BCR-ABL/GUS IS Levels At Diagnosis Are Associated With Unfavorable Responses To Imatinib

Optimizing Early Prediction Of Outcome In CML Using The Exact Decline Of BCR-ABL Transcript Levels Within 3 Months Of Imatinib Treatment As a Prognostic Marker

Aldosterone Stimulates a Degranulation Response in Human Neutrophils: Role of Protein Disulfide Isomerase

Absolute BCR-ABL Transcript Levels At 3 Months but Not At Diagnosis Predict Survival of Chronic Myeloid Leukemia (CML) Patients On Imatinib Therapy

High BCR-ABL Levels At Diagnosis Are Associated with Unfavorable Responses to Imatinib Mesylate.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only